Thomas Klabunde

6.3k total citations · 2 hit papers
51 papers, 4.9k citations indexed

About

Thomas Klabunde is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Thomas Klabunde has authored 51 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 15 papers in Endocrinology, Diabetes and Metabolism and 11 papers in Surgery. Recurrent topics in Thomas Klabunde's work include Diabetes Management and Research (9 papers), Receptor Mechanisms and Signaling (9 papers) and Pancreatic function and diabetes (9 papers). Thomas Klabunde is often cited by papers focused on Diabetes Management and Research (9 papers), Receptor Mechanisms and Signaling (9 papers) and Pancreatic function and diabetes (9 papers). Thomas Klabunde collaborates with scholars based in Germany, United States and Italy. Thomas Klabunde's co-authors include Bernt Krebs, James C. Sacchettini, Norbert Sträter, Gerhard Heßler, Christoph Eicken, Herbert Witzel, Andreas Evers, William N. Lipscomb, Jeffery W. Kelly and Paul A. Tucker and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Thomas Klabunde

50 papers receiving 4.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Crystal structure of a plant catechol oxidase containing a dicopper center

1998 746 citations Thomas Klabunde, Christoph Eicken et al. Nature Structural Biology profile →
Two‐Metal Ion Catalysis in Enzymatic Acyl‐ and Phosphoryl‐Transfer Reactions

1996 553 citations Norbert Sträter, Thomas Klabunde et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Klabunde Germany	31	2.8k	985	688	684	577	51	4.9k
B.C. Finzel United States	29	4.0k 1.4×	719 0.7×	511 0.7×	755 1.1×	1.2k 2.1×	69	6.4k
John W. Kozarich United States	43	5.2k 1.9×	1.7k 1.7×	1.9k 2.8×	620 0.9×	910 1.6×	141	7.7k
Jordan Tang United States	53	4.8k 1.7×	996 1.0×	757 1.1×	258 0.4×	746 1.3×	173	9.1k
Michał Rostkowski Poland	12	3.6k 1.3×	391 0.4×	628 0.9×	232 0.3×	777 1.3×	25	5.3k
Michael Hennig Switzerland	38	3.2k 1.1×	735 0.7×	620 0.9×	178 0.3×	757 1.3×	88	4.9k
David J. Maloney United States	43	3.3k 1.2×	905 0.9×	991 1.4×	194 0.3×	260 0.5×	140	5.6k
Chresten R. Søndergaard Ireland	9	3.7k 1.3×	392 0.4×	587 0.9×	209 0.3×	803 1.4×	12	5.3k
Steven W. Muchmore United States	26	3.3k 1.2×	496 0.5×	466 0.7×	187 0.3×	425 0.7×	49	4.6k
Gary D. Brayer Canada	44	4.7k 1.7×	400 0.4×	726 1.1×	211 0.3×	1.4k 2.4×	92	7.0k
Karen N. Allen United States	43	4.0k 1.4×	268 0.3×	613 0.9×	245 0.4×	1.9k 3.2×	137	5.8k

Countries citing papers authored by Thomas Klabunde

Since Specialization

Citations

This map shows the geographic impact of Thomas Klabunde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Klabunde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Klabunde more than expected).

Fields of papers citing papers by Thomas Klabunde

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Klabunde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Klabunde. The network helps show where Thomas Klabunde may publish in the future.

Co-authorship network of co-authors of Thomas Klabunde

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Klabunde. A scholar is included among the top collaborators of Thomas Klabunde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Klabunde. Thomas Klabunde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schiavon, Michele, R. Visentin, Jochen Sieber, et al.. (2020). In Silico Head-to-Head Comparison of Insulin Glargine 300 U/mL and Insulin Degludec 100 U/mL in Type 1 Diabetes. Diabetes Technology & Therapeutics. 22(8). 553–561. 17 indexed citations

Sacco, Francesca, Sean J. Humphrey, Jürgen Cox, et al.. (2016). Glucose-regulated and drug-perturbed phosphoproteome reveals molecular mechanisms controlling insulin secretion. Nature Communications. 7(1). 13250–13250. 71 indexed citations

Schneider, Hans-Christoph & Thomas Klabunde. (2012). Understanding drugs and diseases by systems biology?. Bioorganic & Medicinal Chemistry Letters. 23(5). 1168–1176. 20 indexed citations

Klabunde, Thomas & Robert De Jager. (2007). Chemogenomics Approaches to G-Protein Coupled Receptor Lead Finding. PubMed. 31–46. 5 indexed citations

Oikonomakos, Nikos G., Magda Kosmopoulou, Evangelia D. Chrysina, et al.. (2005). Crystallographic studies on acyl ureas, a new class of glycogen phosphorylase inhibitors, as potential antidiabetic drugs. Protein Science. 14(7). 1760–1771. 21 indexed citations

Klabunde, Thomas & Andreas Evers. (2005). GPCR Antitarget Modeling: Pharmacophore Models for Biogenic Amine Binding GPCRs to Avoid GPCR‐Mediated Side Effects. ChemBioChem. 6(5). 876–889. 58 indexed citations

Kostenis, Evi, Thomas Klabunde, Stefanie Flohr, et al.. (2003). Functional and Binding Characterizations of Urotensin II-Related Peptides in Human and Rat Urotensin II-Receptor Assay. Journal of Pharmacology and Experimental Therapeutics. 306(3). 1200–1209. 54 indexed citations

Klabunde, Thomas & Gerhard Heßler. (2002). Drug Design Strategies for Targeting G-Protein-Coupled Receptors. ChemBioChem. 3(10). 928–944. 390 indexed citations

Eicken, Christoph, Vivek Sharma, Thomas Klabunde, et al.. (2002). Crystal Structure of Lyme Disease Variable Surface Antigen VlsE of Borrelia burgdorferi. Journal of Biological Chemistry. 277(24). 21691–21696. 112 indexed citations

10.

Matter, Hans, et al.. (2001). Computational Approaches Towards the Rational Design of Drug-like Compound Libraries. Combinatorial Chemistry & High Throughput Screening. 4(6). 453–475. 46 indexed citations

11.

Eicken, Christoph, Vivek Sharma, Thomas Klabunde, et al.. (2001). Crystal Structure of Lyme Disease Antigen Outer Surface Protein C from Borrelia burgdorferi. Journal of Biological Chemistry. 276(13). 10010–10015. 79 indexed citations

12.

Sacchettini, James C., Donald R. Ronning, Thomas Klabunde, et al.. (2000). Crystal structure of the secreted form of antigen 85C reveals potential targets for mycobacterial drugs and vaccines.. Nature Structural Biology. 7(2). 141–146. 141 indexed citations

13.

Klabunde, Thomas, Christoph Eicken, James C. Sacchettini, & Bernt Krebs. (1998). Crystal structure of a plant catechol oxidase containing a dicopper center. Nature Structural Biology. 5(12). 1084–1090. 746 indexed citations breakdown →

14.

Klabunde, Thomas, Sujata Sharma, Amalio Telenti, William R. Jacobs, & James C. Sacchettini. (1998). Crystal structure of GyrA intein from Mycobacterium xenopi reveals structural basis of protein splicing. Nature Structural Biology. 5(1). 31–36. 191 indexed citations

15.

Peterson, Scott, Thomas Klabunde, Hilal A. Lashuel, et al.. (1998). Inhibiting transthyretin conformational changes that lead to amyloid fibril formation. Proceedings of the National Academy of Sciences. 95(22). 12956–12960. 169 indexed citations

16.

Klabunde, Thomas, Norbert Sträter, Roland Fröhlich, Herbert Witzel, & Bernt Krebs. (1996). Mechanism of Fe(III) – Zn(II) Purple Acid Phosphatase Based on Crystal Structures. Journal of Molecular Biology. 259(4). 737–748. 305 indexed citations

17.

Sträter, Norbert, Thomas Klabunde, Paul A. Tucker, Herbert Witzel, & Bernt Krebs. (1995). Crystal Structure of a Purple Acid Phosphatase Containing a Dinuclear Fe(III)-Zn(II) Active Site. Science. 268(5216). 1489–1492. 368 indexed citations

18.

Klabunde, Thomas, Norbert Sträter, Bernt Krebs, & Herbert Witzel. (1995). Structural relationship between the mammalian Fe(III)‐Fe(II) and the Fe(III)‐Zn(II) plant purple acid phosphatases. FEBS Letters. 367(1). 56–60. 82 indexed citations

19.

Klabunde, Thomas, Bernd Stahl, Stefanie Hahner, et al.. (1994). The Amino Acid Sequence of the Red Kidney Bean Fe(III)‐Zn(II) Purple Acid Phosphatase. European Journal of Biochemistry. 226(2). 369–375. 52 indexed citations

20.

Stahl, Bernd, Thomas Klabunde, Herbert Witzel, et al.. (1994). The oligosaccharides of the Fe(III)‐Zn(II) purple acid phosphatase of the red kidney bean. European Journal of Biochemistry. 220(2). 321–330. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact